CIC
BMY icon

Cornercap Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Cornercap Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.01M Sell
37,213
-508
-1% -$24.4K 0.99% 16
2025
Q3 		$1.7M Sell
37,721
-635
-2% -$29.7K 0.85% 34
2025
Q2 		$1.78M Sell
38,356
-916
-2% -$45K 0.92% 18
2025
Q1 		$2.4M Sell
39,272
-548
-1% -$31.9K 1.26% 7
2024
Q4 		$2.25M Sell
39,820
-1,693
-4% -$94.6K 0.73% 9
2024
Q3 		$2.15M Sell
41,513
-16,951
-29% -$795K 0.64% 9
2024
Q2 		$2.43M Sell
58,464
-3,364
-5% -$151K 0.4% 42
2024
Q1 		$3.35M Sell
61,828
-1,750
-3% -$89.1K 0.52% 18
2023
Q4 		$3.26M Buy
63,578
+2,708
+4% +$142K 0.53% 14
2023
Q3 		$3.53M Buy
60,870
+5,474
+10% +$335K 0.64% 10
2023
Q2 		$3.54M Buy
55,396
+1,709
+3% +$115K 0.62% 13
2023
Q1 		$3.72M Buy
53,687
+842
+2% +$59.4K 0.65% 8
2022
Q4 		$3.8M Sell
52,845
-2,717
-5% -$205K 0.66% 10
2022
Q3 		$3.95M Buy
55,562
+3,916
+8% +$284K 0.75% 8
2022
Q2 		$3.98M Sell
51,646
-3,681
-7% -$280K 0.69% 11
2022
Q1 		$4.04M Buy
55,327
+1,253
+2% +$84.1K 0.45% 29
2021
Q4 		$3.37M Buy
54,074
+10,194
+23% +$598K 0.49% 32
2021
Q3 		$2.6M Sell
43,880
-453
-1% -$29.8K 0.3% 72
2021
Q2 		$2.96M Buy
44,333
+629
+1% +$41K 0.33% 68
2021
Q1 		$2.76M Buy
43,704
+39,098
+849% +$2.43M 0.31% 84
2020
Q4 		$296K Sell
4,606
-35,626
-89% -$2.19M 0.04% 395
2020
Q3 		$2.43M Buy
+40,232
New +$2.42M 0.34% 94
2020
Q1 		– Sell
-4,606
Closed -$296K – 395
2019
Q4 		$296K Sell
4,606
-47,058
-91% -$2.7M 0.04% 377
2019
Q3 		$2.62M Sell
51,664
-2,650
-5% -$125K 0.37% 94
2019
Q2 		$2.46M Sell
54,314
-826
-1% -$38.5K 0.32% 99
2019
Q1 		$2.63M Buy
55,140
+385
+0.7% +$19.2K 0.36% 94
2018
Q4 		$2.85M Buy
54,755
+25,683
+88% +$1.38M 0.44% 77
2018
Q3 		$1.8M Buy
+29,072
New +$1.73M 0.24% 129
2017
Q3 		– Sell
-9,085
Closed -$507K – 391
2017
Q2 		$507K Buy
+9,085
New +$494K 0.08% 306

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Cornercap Investment Counsel's BMY Position: Q4 2025 in Review

Cornercap Investment Counsel reduced its Bristol-Myers Squibb (BMY) stake by 1.3% in Q4 2025, selling an estimated $24.4K and leaving 37,213 shares worth $2.01M. The position accounts for 0.99% of the portfolio, ranked #16.

Cornercap Investment Counsel first reported a position in BMY in Q2 2017 and has held it in 29 quarters since. The position peaked at $4.04M in Q1 2022. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Cornercap Investment Counsel held 37,213 shares of Bristol-Myers Squibb worth $2.01M as of Q4 2025.
  • Cornercap Investment Counsel sold 508 Bristol-Myers Squibb shares in Q4 2025, an estimated $24.4K.
  • Bristol-Myers Squibb made up 0.99% of Cornercap Investment Counsel's portfolio in Q4 2025, its #16 holding.
  • Cornercap Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 29 quarters since.
  • Cornercap Investment Counsel's Bristol-Myers Squibb position peaked at $4.04M in Q1 2022.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Cornercap Investment Counsel's 13F filing for Q4 2025, filed 13 Feb 2026.